Physician
Pediatric Specialty Practices, PLLC
Pediatric Specialty Practices, PLLC was paid $3.64M by Medicaid between Sep 2019 and Dec 2024, across 99 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 26% of everything it billed.
33Billing provider infoPEDIATRIC SPECIALTY PRACTICES, PLLC
FEDERAL WAY, WA 98003
FEDERAL WAY, WA 98003
33aNPI1699233080assigned 03/05/2019
33bProvider typePediatric Cardiology Physician
28Total paid$3.64M
24GClaims105,193
24DCodes billed99
24AFirst – last monthSep 2019 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 3,748 | $140K | |
| 2020 | 12,797 | $531K | |
| 2021 | 23,411 | $834K | |
| 2022 | 22,069 | $841K | |
| 2023 | 20,831 | $659K | |
| 2024incomplete | 22,337 | $639K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 26% | 21,034 | 16,765 | $962K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 20% | 10,694 | 8,324 | $722K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 7.2% | 1,009 | 863 | $263K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 7.0% | 4,139 | 3,589 | $254K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.5% | 3,393 | 3,207 | $200K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4.9% | 1,871 | 1,707 | $178K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 4.6% | 2,690 | 2,381 | $167K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.4% | 2,678 | 2,469 | $159K |
| 87631 | 2.7% | 1,221 | 1,067 | $99K | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.6% | 1,083 | 909 | $94K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.1% | 1,257 | 1,191 | $77K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.3% | 1,828 | 1,569 | $48K |
87 more codes
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 1.1% | 431 | $40K |
| 80061 | Lipid panel | <1% | 3,219 | $23K |
| 90670 | <1% | 1,987 | $20K | |
| 92081 | <1% | 1,813 | $17K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 456 | $15K |
| 90680 | <1% | 1,466 | $14K | |
| 90648 | <1% | 1,539 | $13K | |
| 90686 | <1% | 1,492 | $13K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 595 | $12K |
| 98966 | <1% | 1,112 | $11K | |
| 36416 | <1% | 4,625 | $11K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 884 | $11K |
| 99443 | <1% | 210 | $10K | |
| 90633 | <1% | 1,210 | $10K | |
| 99460 | <1% | 152 | $10K | |
| 93320 | <1% | 463 | $10K | |
| 90723 | <1% | 1,000 | $9K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 845 | $9K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 136 | $9K |
| 99442 | <1% | 285 | $9K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 100 | $8K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 498 | $8K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,192 | $7K |
| 99174 | <1% | 3,396 | $6K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 687 | $6K |
| 85018 | <1% | 4,853 | $6K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 724 | $6K |
| 99354 | <1% | 126 | $6K | |
| 82962 | <1% | 2,829 | $5K | |
| 83655 | <1% | 719 | $5K | |
| 90688 | <1% | 583 | $5K | |
| 90698 | <1% | 378 | $4K | |
| 98967 | <1% | 436 | $4K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 509 | $4K |
| 93325 | <1% | 359 | $4K | |
| 90651 | <1% | 498 | $3K | |
| 81002 | <1% | 1,872 | $3K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 65 | $3K |
| 90700 | <1% | 313 | $3K | |
| 0001A | <1% | 127 | $3K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 353 | $3K |
| 90710 | <1% | 333 | $2K | |
| 87428 | <1% | 76 | $2K | |
| 92567 | <1% | 369 | $2K | |
| 96127 | <1% | 730 | $2K | |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) | <1% | 97 | $2K |
| 90707 | <1% | 214 | $2K | |
| 0002A | <1% | 78 | $2K | |
| 99383 | <1% | 29 | $2K | |
| 99381 | <1% | 24 | $2K | |
| 99205 | Prolong outpt/office vis | <1% | 13 | $2K |
| 90672 | <1% | 198 | $2K | |
| 87807 | <1% | 411 | $2K | |
| 90656 | <1% | 498 | $2K | |
| 99382 | <1% | 18 | $2K | |
| 87634 | <1% | 35 | $2K | |
| 0072A | <1% | 55 | $2K | |
| 90716 | <1% | 135 | $1K | |
| 99201 | <1% | 58 | $1K | |
| 90461 | <1% | 162 | $1K | |
| 0071A | <1% | 41 | $1K | |
| 90677 | <1% | 305 | $1K | |
| 99072 | <1% | 1,721 | $1K | |
| 99499 | <1% | 91 | $959.74 | |
| 90474 | <1% | 94 | $830.96 | |
| 90696 | <1% | 135 | $825.11 | |
| 90734 | <1% | 89 | $721.94 | |
| 99173 | <1% | 490 | $634.71 | |
| 90687 | <1% | 103 | $508.21 | |
| 90715 | <1% | 26 | $318.79 | |
| 94375 | <1% | 15 | $261.03 | |
| 90744 | <1% | 20 | $251.28 | |
| 90620 | <1% | 29 | $184.92 | |
| 99188 | <1% | 65 | $159.00 | |
| 94760 | <1% | 492 | $142.14 | |
| 90619 | <1% | 56 | $121.87 | |
| 93000 | <1% | 14 | $58.45 | |
| 94664 | <1% | 38 | $32.46 | |
| 96161 | <1% | 179 | $25.65 | |
| 94761 | <1% | 44 | $17.15 | |
| 96160 | <1% | 55 | $12.34 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 37 | $2.48 |
| 99000 | 0% | 13 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 31 | $0.00 |
| 87581 | 0% | 14 | $0.00 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 0% | 14 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAHMAD, NAUMAN (MANAGING DIRECTOR)